please contact sales@tanchin.hk for any inquiry
According to Thomson Reuters, IFR reported on Thursday that the world information technology limited, which operates the headhunting and recruiting service platform with the "hunting" brand, began to advance its $3-5 billion in Hongkong IPO (first public offer); in addition, Chinese medicine has submitted its application to the Hongkong stock exchange for a new example. "Into the table" of biotech company.
The world information technology was founded by Dai Kebin, the chairman and chief executive officer of the company, and other major shareholders, including private Holdings Company Huaping investment and Matrix Partners.
By the end of 2017, the company's platform linked and absorbed about 38 million 900 thousand registered personal users, 248 thousand and 600 verification enterprise users and 101 thousand and 800 verification headhunters, according to the company's first edition. It recorded a net profit of 7 million 550 thousand yuan in 2017 and a loss of 140 million yuan in the previous year. JP Morgan and JPMorgan are co sponsors of IPO.
In addition, China's nuclear industry group is engaged in the diagnosis and treatment of radiopharmaceuticals and product manufacturers - China's same Limited by Share Ltd and the largest Internet home platform --Qeeka Home in China, which also started presentations today, with a scale of about $200 million in IPO.
The Chinese medicine plant, China lead medicine, has applied to the stock exchange for second unprofitable biotech companies to be listed since the launch of the new and innovative industry company in 0388.HK in April. Ascletis, which has focused on antiviral, cancer and fatty liver diseases, has submitted its application. Please.


please contact sales@tanchin.hk for any inquiry
PREVIOUS:Bearing side cover packing Improvement        

62305-2RSR 62304-2RSR 62303-2RSR 62302-2RSR 6418-M 6417-M 6416-M 6415-M 6414 6413 6412 6411 6410 6409 6408 6407 6406 6405 6404 6403